Bluesky Explorer

#COM701

Latest posts tagged with #COM701 on Bluesky

Trending

#MJF Tribute #WBC #Javier Bardem #Marty Supreme #Andrade #Jessie Buckley #Academy Awards #Autumn Durald Arkapaw #MBJ #Wallace #MJF Tribute #WBC #Javier Bardem #Marty Supreme #Andrade #Jessie Buckley #Academy Awards #Autumn Durald Arkapaw #MBJ #Wallace

Posts tagged #COM701

Thiard News@F4F

@newsen.bsky.social

4 months ago

Preview

Compugen's Third Quarter 2025 Financial Performance and Clinical Updates Highlight Its Strategic Direction Compugen Ltd. releases its financial results for Q3 2025, highlighting advancements in cancer immunotherapy and strategic collaborations that aim for impactful efficacy in treatment.

Compugen's Third Quarter 2025 Financial Performance and Clinical Updates Highlight Its Strategic Direction #Israel #Cancer_Immunotherapy #Compugen #Holon #COM701

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

5 months ago

Preview

Compugen to Showcase COM701 Efficacy Analysis at ESMO 2025 for Ovarian Cancer Compugen Ltd. will present a pooled analysis of COM701 in ovarian cancer patients at ESMO 2025, highlighting its potential as a pivotal treatment.

Compugen to Showcase COM701 Efficacy Analysis at ESMO 2025 for Ovarian Cancer #Israel #Compugen #Holon #COM701 #OvarianCancer

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

7 months ago

Preview

Compugen Announces Positive Developments in Cancer Therapy Trials and Financials for Q2 2025 Compugen Ltd. reports significant advancements in their cancer therapy trials and reveals solid financial standing for Q2 2025, promising growth ahead.

Compugen Announces Positive Developments in Cancer Therapy Trials and Financials for Q2 2025 #Israel #Cancer_Immunotherapy #Compugen #Holon #COM701

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

7 months ago

Preview

Compugen to Unveil COM701 Phase 1 Trials Analysis at ESMO 2025 in Berlin Discover Compugen's upcoming presentation focusing on the pooled analysis of COM701 Phase 1 trials for platinum-resistant ovarian cancer at ESMO 2025.

Compugen to Unveil COM701 Phase 1 Trials Analysis at ESMO 2025 in Berlin #Israel #Compugen #Holon #Ovarian_Cancer #COM701

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

7 months ago

Preview

Compugen Initiates Groundbreaking Trial for COM701 in Ovarian Cancer Treatment Compugen has officially started dosing patients in a global trial for COM701, an innovative therapy for platinum-sensitive ovarian cancer, aiming for improved patient outcomes.

Compugen Initiates Groundbreaking Trial for COM701 in Ovarian Cancer Treatment #Israel #Compugen #Holon #Ovarian_Cancer #COM701

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

9 months ago

Preview

Compugen Unveils Promising Progress in Cancer Immunotherapy and Financial Stability Compugen reports Q1 2025 results, highlighting ongoing trials for novel cancer therapies and a strong financial outlook, guiding until 2027.

Compugen Unveils Promising Progress in Cancer Immunotherapy and Financial Stability #Israel #cancer_therapy #Compugen #Holon #COM701

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 year ago

Preview

Compugen Reports Promising Q4 and Full Year 2024 Financial Results and Development Milestones Compugen announces its fourth quarter and full year 2024 results, highlighting breakthroughs in cancer immunotherapy development and strong financial performance.

Compugen Reports Promising Q4 and Full Year 2024 Financial Results and Development Milestones #Israel #Compugen #Holon #Gilead #COM701

0 0 0 0